« Back
Home /
SMAD7 Peptide (AAP32008)

SMAD7 Peptide (AAP32008)

Item no.	AAP32008
Manufacturer	AVIVA Systems Biology
Amount	100 ug
Category	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Targets for Rodent Neurosciences Aging & Neurological Disorders Neural Development Neural Adhesion Molecules Peptides & Proteins Western Blot Peptides By Organ Colorectal Cancer Neurodegeneration Markers Glial Cell Markers
Type	Peptides
Format	Lyophilized powder
Applications	WB
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	FLJ16482, MADH7, MADH8
Similar products	SMAD7
Available
Description	This is a synthetic peptide designed for use in combination with anti-SMAD7 antibody (Catalog #: ARP32008_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol	SMAD7
Protein size	426
Molecular weight	46kDa
Product format	Lyophilized powder
Gene id	4092
Reconstitution and storage	Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Partner proteins	SMURF1, SMURF2, ACVR1B, AKT1, ASH1L, AXIN1, BMPR1B, CTNNB1, CXXC5, DVL1, EP300, ERBB2IP, HAT1, HEYL, KDM2A, MAP2K3, MAP2K6, MAP3K7, MAPK14, MBD1, MYOD1, PARD3, PIAS1, PIAS4, RNF111, SASH3, SMAD6, SMAD7, SMURF1, SMURF2, SOX13, SOX5, SOX7, STAMBP, STAMBPL1, STRAP, TAB1, TGFBR1, TGFBR2, TTF1, TTF2, XRCC6, YAP1, ZBTB11, ZBTB44, ZNF107, ACVR1B, AKT1, BMPR1A, CTNNB1, DVL1, EP300, ERBB2IP, LEF1, MAP2K3, MAP2K6, MAP3K7, MAPK14, PARD3B, PIAS4, RNF111, SMAD2, SMAD3, SMAD4, SMAD6, SMURF1, SMURF2, STAMBP, STRAP, TAB1, TGFBR1, TGFBR2, Wwp2, YAP1
Description of target	Smad7 acts to functionally inactivate RB and de-repress E2F without blocking the activation of TbetaRI and the nuclear translocation of Smad2/3, allowing TGF-beta1 to exert effects in a cancer cell that is resistant to TGF-beta1-mediated growth inhibition.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

AAP32008-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 10/30/2025

Express Delivery: Save 20 days

Compare

Add to wishlist

Get an offer